Covered recipient · General Payments record
DUSTIN J MARTIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$1,044.23
- Reported across 27 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $450.81 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $144.90 | 1 |
| Acerta Pharma LLC | $112.48 | 3 |
| Novo Nordisk AS | $49.44 | 3 |
| Lilly USA, LLC | $32.08 | 2 |
| GlaxoSmithKline, LLC. | $31.82 | 2 |
| Lundbeck LLC | $27.50 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $19.48 | 1 |
| PFIZER INC. | $18.57 | 1 |
| ABBVIE INC. | $14.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.54 | 08/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104972983 | CMS |
| AstraZeneca Pharmaceuticals LP | $78.73 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104738293 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.84 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104766618 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.91 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105253811 | CMS |
| Boston Scientific Corporation | $19.48 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092307496 | CMS |
| GlaxoSmithKline, LLC. | $17.26 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115857769 | CMS |
| GlaxoSmithKline, LLC. | $14.56 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116533680 | CMS |
| Lilly USA, LLC | $14.35 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134964153 | CMS |
| Lilly USA, LLC | $17.73 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136153422 | CMS |
| Lundbeck LLC | $27.50 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145943128 | CMS |
| Medtronic, Inc. | $144.90 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119582157 | CMS |
| Novo Nordisk Inc | $19.56 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097832729 | CMS |
| Novo Nordisk Inc | $15.90 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097690396 | CMS |
| Novo Nordisk Inc | $13.98 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097343709 | CMS |
| PFIZER INC. | $18.57 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131540948 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.